Molecular Diagnostics

Personalised medicine is moving from science fiction to reality.

In Vitro Diagnostics currently represent an expanding market of around $30 billon – with Molecular Diagnostics represent a growing fraction of this market. Drugs developed with pharmacogenetic companion diagnostics hold a phenomenal potential to optimise treatments for patients and make enourmous profits for those who commercialise them.

As increasing understanding of genomics allows medical interventions to be tailored to the patient, SMi’s Molecular Diagnostics Conference will provide the perfect opportunity to keep abreast of developments. Both diagnostics companies and drug producers will benefit from hearing the latest thinking on diagnostic testing and pharmacogenetics.

With a panel of top industry experts, the conference will address a number of key areas including:

• Developing companion diagnostics
• Discovering and validating molecular biomarkers
• Improving drug efficacy with personalised medicine
• Using pharmacogenomics to increase drug safety
• Market prospects and the health economics of diagnostics and personalised medicine
• The regulatory regime for diagnostic tests

Confirmed speakers:

• Eddie Blair, Managing Director, Integrated Medicines
• Anil Modak, Associate Director, Medical Products Research and Development, Cambridge Isotope Laboratories
• Glenn Miller, Vice President, General Manager, Genzyme
• Ansar Jawaid, Statistical Genetics Group Leader, R&D Genetics, AstraZeneca
• Daren Thorborn, HIV Project Leader, GlaxoSmithKline
• David Johnston, Vice President and Chief Scientific Officer, Esoterix Clinical Trials Services
• Angus Hastie, CEO, Human Genetic Signatures
• David Huckle, Chief Executive, Adams Business Associates
• Steven Wong, Professor of Pathology & Scientific Director, toxicology Department, Milwaukee County Examiners Office, Medical University of Wisconsin
• Professor K.K. Jain, CEO, Jain PharmaBiotech
• Eric Claas, Associate Professor, Department of Medical Microbiology, Leiden University Medical Centre
• Fiona Rahman, Programme Manager - Clinical Diagnostics Healthcare EIA, Frost & Sullivan
• Sian Astley, European Communications Manager, Norwich Bioscience Institutes & NuGO
• Muireann Cohen, Research Associate, Imperial College London
• Jorge Leon, CEO, Leomics Consulting